Universe Pharmaceuticals Inc
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong … Read more
Universe Pharmaceuticals Inc (UPC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: -0.136x
Based on the latest financial reports, Universe Pharmaceuticals Inc (UPC) has a cash flow conversion efficiency ratio of -0.136x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-7.61 Million) by net assets ($56.13 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Universe Pharmaceuticals Inc - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Universe Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Universe Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Universe Pharmaceuticals Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mohit Industries Limited
NSE:MOHITIND
|
0.003x |
|
Alakasa Industrindo Tbk
JK:ALKA
|
0.034x |
|
Puri Global Sukses Tbk Pt
JK:PURI
|
-0.151x |
|
Asiabasemetals Inc
V:ABZ
|
-0.004x |
|
SPARTOO SAS EO -02
F:7ZP
|
N/A |
|
STRAP
CO:STRAP
|
0.000x |
|
Universal PropTech Inc
PINK:UPIPF
|
0.013x |
|
Gamla Harel Residential Real-Estate Ltd
TA:GMLA
|
0.275x |
Annual Cash Flow Conversion Efficiency for Universe Pharmaceuticals Inc (2018–2025)
The table below shows the annual cash flow conversion efficiency of Universe Pharmaceuticals Inc from 2018 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $56.13 Million | $-5.05 Million | -0.090x | +56.92% |
| 2024-09-30 | $45.50 Million | $-9.51 Million | -0.209x | -837.39% |
| 2023-09-30 | $39.53 Million | $1.12 Million | 0.028x | +200.27% |
| 2022-09-30 | $46.44 Million | $-1.31 Million | -0.028x | +18.99% |
| 2021-09-30 | $58.93 Million | $-2.06 Million | -0.035x | -111.87% |
| 2020-09-30 | $20.80 Million | $6.12 Million | 0.294x | -72.43% |
| 2019-09-30 | $12.38 Million | $13.20 Million | 1.066x | +131.67% |
| 2018-09-30 | $9.68 Million | $4.46 Million | 0.460x | -- |